Checkmate Pharmaceuticals, Inc. Current Ratio 2020-2022 | CMPI
Checkmate Pharmaceuticals, Inc. current ratio from 2020 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2022-03-31 |
$0.06B |
$0.01B |
5.20 |
2021-12-31 |
$0.07B |
$0.01B |
7.89 |
2021-09-30 |
$0.09B |
$0.01B |
11.35 |
2021-06-30 |
$0.09B |
$0.01B |
13.59 |
2021-03-31 |
$0.09B |
$0.01B |
12.87 |
2020-12-31 |
$0.10B |
$0.01B |
12.97 |
2020-09-30 |
$0.14B |
$0.01B |
16.26 |
2020-06-30 |
$0.08B |
$0.01B |
11.95 |
2020-03-31 |
$0.01B |
$0.01B |
1.01 |
2019-12-31 |
$0.01B |
$0.01B |
0.91 |
2019-09-30 |
$0.00B |
|
0.00 |
2019-06-30 |
$0.00B |
|
0.00 |
2019-03-31 |
$0.00B |
|
0.00 |